The Subarachnoid Hemorrhage International Trialists (SAHIT) Repository: Advancing Clinical Research in Subarachnoid Hemorrhage

Neurocritical Care

Volumn 21, Issue 3, 2014, Pages 551-559

  Jaja, Blessing N R ^a   Attalla, Daniel ^a   Macdonald, R Loch ^a   Schweizer, Tom A ^a   Cusimano, Michael D ^a   Etminan, Nima ^b   Hanggi, Daniel ^b   Hasan, David ^c   Johnston, S Claiborne ^d   Le Roux, Peter ^e   Lo, Benjamin ^a   Louffat Olivares, Ada ^a   Mayer, Stephan ^f   Molyneux, Andrew ^g   Noble, Adam ^h   Quinn, Audrey ⁱ   Schenk, Thomas ^j   Spears, Julian ^a   Singh, Jeffrey ^a   Todd, Michael ^c   Torner, James ^c   Tseng, Ming ^k   van den Bergh, William ^l   Vergouwen, Mervyn D I ^m   Wong, George K C ⁿ   more..

^a UNIVERSITY OF TORONTO   (Canada)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f Columbia University ^*  (United States)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h KING'S COLLEGE LONDON   (United Kingdom)

ⁱ LEEDS GENERAL INFIRMARY   (United Kingdom)

^j UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^k MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

^l UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^m UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁿ CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

more..

Author keywords

Cerebrovascular disease; Clinical trials; Database; Intracranial aneurysm; Stroke; Subarachnoid hemorrhage

Indexed keywords

FACTUAL DATABASE; HUMAN; MEDICAL RESEARCH; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

BIOMEDICAL RESEARCH; DATABASES, FACTUAL; HUMANS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 84936748050     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-014-9990-y     Document Type: Article

References (32)

1. Korja M, Silventoinen K, Laatikainen T, Jousilahti P, Salomaa V, Kaprio J. Cause-specific mortality of 1-year survivors of subarachnoid hemorrhage. Neurology. 2013;80:481–6.
2. Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41:519–36.
3. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8:635–42.
4. Lovelock CE, Rinkel GJE, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage population-based study and systematic review. Neurology. 2010;74:1494–501.
5. Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994–1025.
6. Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636–42.
7. Molyneux A, Kerr R, Stratton I, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267–74.
8. Macdonald RL, Jaja B, Cusimano MD, et al. SAHIT investigators-on the outcome of some subarachnoid hemorrhage clinical trials. Transl Stroke Res. 2013;4:286–96.
9. Macdonald RL, Cusimano MD, Etminan N, et al. Subarachnoid Hemorrhage International Trialists data repository (SAHIT). World Neurosurg. 2013;79:418–22.
10. Maas AI, Steyerberg EW, Marmarou A, et al. IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury. Neurotherapeutics. 2010;7:127–34.
11. Bath PM, Lees KR, Schellinger PD, et al. Statistical analysis of the primary outcome in acute stroke trials. Stroke. 2012;43:1171–8.
12. van den Bergh WM, Algra A, van KF, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2005;36:1011–5.
13. Wong GKC, Poon WS, Chan MTV, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH) a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke. 2010;41:921–6.
14. Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39:3015–21.
15. Todd MM, Hindman BJ, Clarke WR, Torner JC. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med. 2005;352:135–45.
16. Johnston SC, McDougall CG, Gholkar A. The MAPS trial—Matrix and Platinum Science-clinical trials. Colorado: Colorado Spring; 2011.
17. Etminan N, Beseoglu K, Eicker SO, Turowski B, Steiger HJ, Hanggi D. Prospective, randomized, open-label phase II trial on concomitant intraventricular fibrinolysis and low-frequency rotation after severe subarachnoid hemorrhage. Stroke. 2013;44:2162–8.
18. Noble AJ, Schenk T. Which variables help explain the poor health-related quality of life after subarachnoid hemorrhage? A meta-analysis. Neurosurgery. 2010;66:772–83.
19. Helbok R, Kurtz P, Vibbert M, Schmidt MJ, Fernandez L, Lantigua H, et al. Early neurological deterioration after subarachnoid haemorrhage: risk factors and impact on outcome. J Neurol Neurosurg Psychiatry. 2013;84:266–70.
20. Smith ML, Abrahams JM, Chandela S, Smith MJ, Hurst RW, Le Roux PD. Subarachnoid hemorrhage on computed tomography scanning and the development of cerebral vasospasm: the Fisher grade revisited. Surg Neurol. 2005;63:229–35.
21. Reilly C, Amidei C, Tolentino J, Jahromi BS, MacDonald RL. Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2004;101:255–61.
22. Drake CG, Hunt WE, Sano K, Kassell N, Teasdale G, Pertuiset B, et al. Report of World Federation of Neurological Surgeons committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg. 1988;68:985–6.
23. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14–20.
24. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6:1–9.
25. Hijdra A, Brouwers PJ, Vermeulen M, van GJ. Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke. 1990;21:1156–61.
26. Ali M, Bath PM, Curram J, et al. The virtual international stroke trials archive. Stroke. 2007;38:1905–10.
27. Marmarou A, Lu J, Butcher I, et al. IMPACT database of traumatic brain injury: design and description. J Neurotrauma. 2007;24:239–50.
28. Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: surgical results. J Neurosurg. 1990;73:37–47.
29. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: overall management results. J Neurosurg. 1990;73:18–36.
30. Johnston SC, Dowd CF, Higashida RT, Lawton MT, Duckwiler GR, Gress DR. Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture After Treatment (CARAT) Study. Stroke. 2008;39:120–5.
31. Tseng MY, Hutchinson PJ, Richards HK, et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. J Neurosurg. 2009;111:171–80.
32. Tseng MY, Hutchinson PJ, Turner CL, et al. Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial. J Neurosurg. 2007;107:1092–100.